Clinical Trial Update: Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nogapendekin alfa inbakicept for advanced non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nogapendekin-alfa Inbakicept

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: TERMINATED